LKQ’s July forecast could not be met on the company’s own numbers, and Friday’s selloff is the market saying so. The auto-parts distributor closed at $17.42, down 22.5% from Thursday’s $22.47, after it pulled its 2026 guidance, reported a revenue miss and a net loss, and lost CEO Justin Jude. The early coverage we read leads with the miss, a $111 million impairment and the leadership change. None of it sets the new numbers against the range management defended on an earnings call 85 days earlier, and that comparison is the story.
The Arithmetic Behind the Withdrawn Range
On July 30, LKQ cut its 2026 adjusted EPS outlook to $2.60 to $2.90 from $2.90 to $3.20, and management told investors on the call that the range “appropriately reflects the current pace of recovery and the operating risks we see in the second half.” Adjusted EPS was $0.67 in the first quarter and $0.67 in the second. Friday’s release puts the third quarter at 47 to 53 cents. Subtracting those from the July range gives the fourth quarter LKQ needed:
| July 30 outlook | Full-year adjusted EPS | Fourth-quarter EPS required |
|---|---|---|
| Low end | $2.60 | $0.73 to $0.79 |
| Midpoint | $2.75 | $0.88 to $0.94 |
| High end | $2.90 | $1.03 to $1.09 |
For comparison, LKQ earned $0.59 in the fourth quarter of 2025, itself 24% below the year before. Even the floor of the range needed a fourth quarter 24% to 34% above that, from a company whose best quarter this year is $0.67. We think the range was a placeholder, set to calm the market rather than to forecast, and the board should have said so in July.
Europe Got Worse After Management Said the Worst Was Over
On the same call, management said of the Germany software conversion that “the most difficult scaling step is now behind us, the recovery is underway.” It put the conversion’s cost at about $140 million of second-quarter revenue and $50 million of Europe EBITDA, and a further $30 million on weak UK and Benelux volumes. Europe’s second-quarter EBITDA margin was 7.5%, on $109 million of EBITDA and $1.455 billion of revenue.
That claim was testable. Add the $50 million back and Europe’s second-quarter margin would have been about 10.9%, above the 9.4% it earned a year earlier. If the conversion were the whole problem, the third quarter should have shown it healing. Instead Friday’s release puts the Europe margin at 4.1% to 5.1%, against 10.0% a year ago, even as organic parts and services revenue fell 9.8%, a smaller drop than the second quarter’s 12.6%. Revenue is recovering slowly. Profit is not recovering at all, which points to cost and execution problems beyond one software rollout. LKQ has now hired Alvarez & Marsal to advise on European operations, citing customer service, operational stability and cost discipline.
The Impairment Is Not the Cause
The GAAP loss of 6 to 12 cents a share carries $111 million of non-cash charges, $88 million of goodwill and $23 million of net assets held for sale. LKQ’s adjusted figures exclude impairments, which its July release states plainly, so the 47 to 53 cents already has them stripped out. At the 50-cent midpoint that is about 40% below the 84 cents of a year ago and about 28% below the 69 cents analysts expected. The operating business missed. The impairment is bookkeeping catching up.
What a Buyer Sees Now
LKQ is in a review of strategic alternatives that includes a sale of the company. Our read is that Friday made a whole-company sale harder. A bidder now inspects a Europe segment earning a low-to-mid single-digit margin, a departed Europe president, a CEO who leaves immediately, an interim two-person office running the company until Salvatore Abbate starts on December 15, and no guidance. North America, which LKQ says is in line with expectations, earned a 14.1% margin in the second quarter. The cleaner proposition is that business and Specialty without Europe, and the board should say whether it is willing to sell on those terms.
The company reports full third-quarter results on October 29. Watch Europe’s revenue and EBITDA in dollars, whether the Germany conversion is described as finished, and whether the strategic review gets its promised update.